Therapy for Migraine Prevention in Children 6-11 Years of Age

NCT04050293 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty in recruitment

Conditions

Migraine Disorders
Headache Disorders

Interventions

DRUG: SPN-538
DRUG: Placebo

Sponsor

Supernus Pharmaceuticals, Inc.